Maite Bourlon: Press release on CheckMate-67T study of subcutaneous Nivolumab while The European Society for Medical Oncology (ESMO) begins

Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán, shared on Twitter:

“Bristol Myers Squib Press release on CheckMate-67T study of subcutaneous Nivolumab while The European Society for Medical Oncology (ESMO) begins

• P3 trial of SC Nivo vs IV Nivo
• Meets co-primary endpoints of Pharmacokinetics
• Meets non-inferiority in ORR (secondary endpoint)

Great team Laurence Albiges, Comprehensive Care Clinic for Genito-Urinary Tumors.”

Source: Maite Bourlon/Twitter